Bioqual Inc. (OTCMKTS:BIOQ – Get Free Report)’s stock price traded down 3.7% during trading on Monday . The stock traded as low as $38.51 and last traded at $38.51. 283 shares traded hands during mid-day trading, The stock had previously closed at $40.00.
Bioqual Stock Down 3.7%
The stock has a 50-day moving average of $40.26 and a 200 day moving average of $43.45. The stock has a market cap of $34.27 million, a PE ratio of -55.01 and a beta of -0.08.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last issued its earnings results on Tuesday, October 21st. The company reported ($0.28) earnings per share (EPS) for the quarter. Bioqual had a negative return on equity of 1.74% and a negative net margin of 1.32%.The company had revenue of $9.85 million during the quarter.
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Articles
- Five stocks we like better than Bioqual
- What is a Special Dividend?
- Insiders Sold Big at These 3 Stocks—Should You Worry?
- Why Are These Companies Considered Blue Chips?
- Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops
- Using the MarketBeat Dividend Tax Calculator
- Nuclear Stocks Are Melting Down—Should Investors Panic?
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
